Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74,822,111
-
Total 13F shares
-
73,689,460
-
Share change
-
-2,165,881
-
Total reported value
-
$1,258,647,401
-
Put/Call ratio
-
52%
-
Price per share
-
$17.08
-
Number of holders
-
180
-
Value change
-
-$22,924,914
-
Number of buys
-
83
-
Number of sells
-
89
Institutional Holders of Zymeworks Inc. - Common Stock (ZYME) as of Q3 2025
As of 30 Sep 2025,
Zymeworks Inc. - Common Stock (ZYME) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,689,460 shares.
The largest 10 holders included
EcoR1 Capital, LLC, Rubric Capital Management LP, BlackRock, Inc., MORGAN STANLEY, BVF INC/IL, Redmile Group, LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Vestal Point Capital, LP, and UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC.
This page lists
180
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.